Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Does Stopping ICI Therapy Affect Survival in HNSCC?
TOPLINE: Patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) treated with immune checkpoint inhibitors (ICIs) show comparable survival outcomes whether they continued or discontinued treatment at 1 or 2 years vs continued past those points. METHODOLOGY:…
English